What drove the difference between Constellation's GAAP and non-GAAP results in 2023?

The gap is mainly driven by items management excludes from Adjusted EBITDA: unrealized fair value losses on economic hedges ($658 million for the full year, $1,002 million in Q4), decommissioning-related activity (a $716 million gain for the full year), income tax expense ($840 million), depreciation and amortization ($1,096 million), and interest expense ($431 million). Investors should review the reconciliation tables, since non-GAAP measures are not standardized and are not a substitute for GAAP net income.

How does the nuclear production tax credit affect Constellation's earnings outlook?

The PTC provides a revenue floor for the nuclear fleet. Per the company's modeling, the credit supports up to $15.00/MWh when revenues fall between $25.00/MWh and $43.75/MWh in 2024, which gives management visibility into base earnings. It also preserves upside when market prices are higher, and the inflation-indexed floor rises over time. The company estimates that roughly 82% of the nuclear fleet is in the PTC zone in 2024, rising to 87% in 2025. The credit runs through 2032.

What is the outlook for capital returns and the balance sheet?

Management plans a 25% dividend increase for 2024 and targets 10% annual dividend growth afterward. It has authorized a second $1 billion buyback, with about $150 million executed by February 27, 2024. The company said it expects about $5.7-$6.1 billion of capital available to allocate over 2024-2025, after identified growth investments and dividends. Long-term debt increased to $7.5 billion at year-end 2023, and management expects to maintain investment-grade credit ratings.

What are the main risks investors should consider from this filing?

Key risks include the sustainability of 2023 market and portfolio gains, which contributed heavily to Adjusted EBITDA; the timing and inflation-indexed value of the PTC; and the roll-off of state programs (New York ZEC through 2029, Illinois CMC through May 2027, and New Jersey ZEC, where no awards were made for the third tranche). Nuclear outages, labor and contracting cost pressures, and volatile mark-to-market and decommissioning items also affect reported results. The filing refers investors to the risk factors in the 2023 Form 10-K for a full description.

Why did Constellation provide 2024 guidance on a new non-GAAP basis?

Beginning in 2024, management said it will supplement GAAP net income with Adjusted (non-GAAP) Operating Earnings, which excludes unrealized fair value adjustments, decommissioning-related activity, pension and OPEB non-service credits, separation costs and ERP implementation costs. Management presents this as a way to view underlying performance and to isolate base earnings, which it says are easier to model from generation volumes and prices. Because the company guides on this basis, investors should reconcile the non-GAAP guidance to GAAP results using the appendix tables in the investor presentation.

CEG 8-K: Earnings & Results & Regulation FD

01—Abstract

Summary

Summary of the 8-K filed February 27, 2024. Cited figures are marked; the original filing is the authoritative source.

Constellation Energy (CEG) reported Q4 and full-year 2023 results on February 27, 2024, alongside an investor event that initiated 2024 guidance and a new long-term growth target.

For FY2023, GAAP net income attributable to common shareholders was $1,623 million^a (versus a $160 million loss in 2022), and non-GAAP Adjusted EBITDA rose to $4,025 million from $2,667 million, above the top of the revised $3.8-$4.0 billion guidance range. Q4 2023 was a GAAP net loss of $36 million, driven largely by a $1,002 million unrealized fair value loss, though Adjusted EBITDA increased to $1,137 million from $605 million. The improvement was mainly due to favorable market and portfolio conditions, partly offset by labor, contracting and materials costs, lower ZEC and capacity revenues, and nuclear outages.

The forward-looking story is the more important one for investors. Management initiated 2024 Adjusted Operating EPS guidance of $7.23 to $8.03^b per share, using a new non-GAAP measure that excludes mark-to-market effects, decommissioning activity, and separation costs. Management attributes the earnings visibility to the nuclear production tax credit (PTC) under the Inflation Reduction Act, which provides a revenue floor for roughly 82-87% of the nuclear fleet.

The company is targeting at least 10% long-term base EPS growth through the decade, a 25% dividend increase for 2024, and a second $1 billion^c share repurchase program, of which about $150 million had been executed by February 27, 2024. Balance-sheet changes also stand out: long-term debt rose to $7.5 billion from $4.5 billion, reflecting financing for the South Texas Project stake acquired for $1.65 billion. Investors should weigh the strong 2023 results against several risks.

Much of the 2023 earnings strength came from market and portfolio conditions, which may not repeat, and the PTC's value depends on gross receipts relative to the phase-out threshold and on inflation-indexed adjustments. The GAAP results are also volatile because of large mark-to-market and decommissioning-related swings, so the non-GAAP figures should be read alongside the GAAP reconciliations. Finally, the state ZEC and CMC programs are set to roll off over 2025-2027, and the New Jersey ZEC program's third tranche was not awarded.

02—Key points

Key Highlights

FY2023 GAAP net income attributable to common shareholders of $1,623 million, versus a $160 million loss in 2022; Adjusted EBITDA (non-GAAP) of $4,025 million, above the top of the revised $3.8-$4.0 billion guidance range.
Q4 2023 GAAP net loss of $36 million, driven by a $1,002 million unrealized fair value loss, while Q4 Adjusted EBITDA rose to $1,137 million from $605 million year over year.
Initiated 2024 Adjusted (non-GAAP) Operating EPS guidance of $7.23 to $8.03, with a new non-GAAP framework beginning in 2024 that excludes mark-to-market, decommissioning and separation items.
Nuclear PTC provides earnings visibility: base earnings of $5.45-$5.55 per share for 2024, with the company targeting at least 10% long-term base EPS growth through the decade.
Shareholder returns: 25% dividend per share increase for 2024 (quarterly dividend of $0.3525 declared), completed the first $1 billion buyback, and started a second $1 billion program (about $150 million executed by February 27, 2024).
Acquired a partial ownership stake in the South Texas Project nuclear plant for $1.65 billion; S&P upgraded the issuer rating to BBB+ (stable), and Moody's rates the company Baa2 (positive outlook).
Long-term debt rose to $7,496 million from $4,466 million at year-end 2022, reflecting financing for the STP acquisition and other growth, which investors should monitor against the company's investment-grade balance sheet goals.

03—Questions

Frequently Asked Questions

What drove the difference between Constellation's GAAP and non-GAAP results in 2023?
The gap is mainly driven by items management excludes from Adjusted EBITDA: unrealized fair value losses on economic hedges ($658 million for the full year, $1,002 million in Q4), decommissioning-related activity (a $716 million gain for the full year), income tax expense ($840 million), depreciation and amortization ($1,096 million), and interest expense ($431 million). Investors should review the reconciliation tables, since non-GAAP measures are not standardized and are not a substitute for GAAP net income.
How does the nuclear production tax credit affect Constellation's earnings outlook?
The PTC provides a revenue floor for the nuclear fleet. Per the company's modeling, the credit supports up to $15.00/MWh when revenues fall between $25.00/MWh and $43.75/MWh in 2024, which gives management visibility into base earnings. It also preserves upside when market prices are higher, and the inflation-indexed floor rises over time. The company estimates that roughly 82% of the nuclear fleet is in the PTC zone in 2024, rising to 87% in 2025. The credit runs through 2032.
What is the outlook for capital returns and the balance sheet?
Management plans a 25% dividend increase for 2024 and targets 10% annual dividend growth afterward. It has authorized a second $1 billion buyback, with about $150 million executed by February 27, 2024. The company said it expects about $5.7-$6.1 billion of capital available to allocate over 2024-2025, after identified growth investments and dividends. Long-term debt increased to $7.5 billion at year-end 2023, and management expects to maintain investment-grade credit ratings.
What are the main risks investors should consider from this filing?
Key risks include the sustainability of 2023 market and portfolio gains, which contributed heavily to Adjusted EBITDA; the timing and inflation-indexed value of the PTC; and the roll-off of state programs (New York ZEC through 2029, Illinois CMC through May 2027, and New Jersey ZEC, where no awards were made for the third tranche). Nuclear outages, labor and contracting cost pressures, and volatile mark-to-market and decommissioning items also affect reported results. The filing refers investors to the risk factors in the 2023 Form 10-K for a full description.
Why did Constellation provide 2024 guidance on a new non-GAAP basis?
Beginning in 2024, management said it will supplement GAAP net income with Adjusted (non-GAAP) Operating Earnings, which excludes unrealized fair value adjustments, decommissioning-related activity, pension and OPEB non-service credits, separation costs and ERP implementation costs. Management presents this as a way to view underlying performance and to isolate base earnings, which it says are easier to model from generation volumes and prices. Because the company guides on this basis, investors should reconcile the non-GAAP guidance to GAAP results using the appendix tables in the investor presentation.

04—Continue

← View all 8-K filings